It is therefore tempting to speculate that BORG is capable of broadly enhancing the same physiologic and oncogenic processes previously attributed to TRIM28, most notably those essential to driving EMT programs62 and expanding cancer stem cell populations in breast cancer46,47. The gene discussed is TRIM28; the disease is cancer.